Influence of darbepoetin-α therapy on HbA1c values in hemodialysis patients

Clinical Nephrology

Volumn 72, Issue 3, 2009, Pages 244-246

  Okada, T ^a   Nakao, T ^a   Yamanaka, T ^a   Tamekuni, T ^a   Ikeda, ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b FUKUOKA SANNO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

ADULT; ALBUMIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE MARKER; DOSE RESPONSE; ERYTHROCYTE LIFESPAN; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOASSAY; LATEX AGGLUTINATION TEST; LETTER; MALE; TREATMENT DURATION;

ERYTHROPOIETIN; FEMALE; HEMATINICS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 70350154706     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp72244     Document Type: Letter

References (11)

1. Ansari A et al. Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis. 2003; 41: 523-531.
2. Biggar P et al. Switch of ESA therapy from darbepoetin-α to epoetin-β in hemodialysis patients: a single-center experience. Clin Nephrol. 2008; 68: 185-192.
3. Chujo K et al. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). J Med Invest. 2006; 53: 223-228.
4. Inaba M et al. Glycated albumin is a better indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol. 2007; 18: 896-903.
5. Koga M et al. Negative association and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chimica Acta. 2007; 378: 48-52.
6. 1c as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract. 2008; 81: 258-262.
7. Moriyama K et al. A case of type 2 diabetes mellitus developing hypothyroidism discovered as a result of a discrepancy between glycated hemoglobin and glycated albumin values. Diabetes Res Clin Pract. 2006; 71: 227-232.
8. 1c levels in patients with chronic renal failure on hemodialysis. Intern Med. 1998; 37: 826-830.
9. Okada T et al. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal failure. Intern Med. 2007; 46: 807-814.
10. Peacock TP et al. Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis. Kidney Int. 2008; 73: 1062-1068.
11. 1c) in type 2 diabetic patients: Usefulness of GA of evaluation of short-term changes in glycemic control. Endocr J. 2007; 54: 139-144.